Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-01-14

FDA Approved: CLORAZEPATE DIPOTASSIUM — Supplemental Application (Aurolife Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for Clorazepate Dipotassium by Aurolife Pharma LLC, granting regulatory approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLORAZEPATE DIPOTASSIUM (Clorazepate dipotassium)

Snippet

SUPPL AP for CLORAZEPATE DIPOTASSIUM (CLORAZEPATE DIPOTASSIUM)